Tech Company Financing Transactions
Collegium Pharmaceutical Funding Round
On 10/3/2013, Collegium Pharmaceutical received $4 million in funding from private investors.
Transaction Overview
Company Name
Announced On
10/3/2013
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Technology Center Dr. 300
Stoughton, MA 02072
USA
Stoughton, MA 02072
USA
Phone
Website
Email Address
Overview
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of products for the treatment of chronic pain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Ciaffoni
Chief Financial Officer
Paul Brannelly
Chief Technical Officer
Alison Fleming
VP - Sales
Scott Dreyer
Browse more venture capital transactions:
Prev: 10/3/2013: NovaDigm Therapeutics venture capital transaction
Next: 10/3/2013: Get Lively venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs